BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/ -- Scorpion Therapeutics, Inc. ("Scorpion"), a pioneering clinical-stage oncology company redefining the frontier of precision medicine through ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the effectiveness of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine. Study: Exosome based ...
"We are excited to begin the clinical evaluation of STX-721, our mutant-selective EGFR ex20ins inhibitor with a potentially best-in-class profile, for the treatment of non-small cell lung cancer," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback